Thalidomide interaction with inflammation in idiopathic pulmonary fibrosis

The “Thalidomide tragedy” is a landmark in the history of the pharmaceutical industry. Despite limited clinical trials, there is a continuous effort to investigate thalidomide as a drug for cancer and inflammatory diseases such as rheumatoid arthritis, lepromatous leprosy, and COVID-19. This review...

Descripción completa

Detalles Bibliográficos
Autores principales: Dsouza, Nikitha Naomi, Alampady, Varun, Baby, Krishnaprasad, Maity, Swastika, Byregowda, Bharath Harohalli, Nayak, Yogendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039777/
https://www.ncbi.nlm.nih.gov/pubmed/36966238
http://dx.doi.org/10.1007/s10787-023-01193-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10039777/
https://www.ncbi.nlm.nih.gov/pubmed/36966238
http://dx.doi.org/10.1007/s10787-023-01193-1

Ejemplares similares